(Q53851964)

English

Identification of N-phenyl-N'-(2,2,6,6-tetramethyl-piperidin-4-yl)-oxalamides as a new class of HIV-1 entry inhibitors that prevent gp120 binding to CD4.

scientific article published in September 2005

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

21 May 2018

http://europepmc.org/abstract/MED/15996703

Identification of N-phenyl-N'-(2,2,6,6-tetramethyl-piperidin-4-yl)-oxalamides as a new class of HIV-1 entry inhibitors that prevent gp120 binding to CD4. (English)

1 reference

Europe PubMed Central

21 May 2018

http://europepmc.org/abstract/MED/15996703

3

object named as

Shibo Jiang

1 reference

Europe PubMed Central

21 May 2018

http://europepmc.org/abstract/MED/15996703

author name string

Qian Zhao

1

1 reference

Europe PubMed Central

21 May 2018

http://europepmc.org/abstract/MED/15996703

Liying Ma

2

1 reference

Europe PubMed Central

21 May 2018

http://europepmc.org/abstract/MED/15996703

Hong Lu

4

1 reference

Europe PubMed Central

21 May 2018

http://europepmc.org/abstract/MED/15996703

Shuwen Liu

5

1 reference

Europe PubMed Central

21 May 2018

http://europepmc.org/abstract/MED/15996703

Yuxian He

6

1 reference

Europe PubMed Central

21 May 2018

http://europepmc.org/abstract/MED/15996703

Nathan Strick

7

1 reference

Europe PubMed Central

21 May 2018

http://europepmc.org/abstract/MED/15996703

Nouri Neamati

8

1 reference

Europe PubMed Central

21 May 2018

http://europepmc.org/abstract/MED/15996703

Asim Kumar Debnath

9

1 reference

Europe PubMed Central

21 May 2018

http://europepmc.org/abstract/MED/15996703

language of work or name

0 references

publication date

1 September 2005

1 reference

Europe PubMed Central

21 May 2018

http://europepmc.org/abstract/MED/15996703

number of pages

13

1 reference

based on heuristic

inferred from page(s)

1 reference

Europe PubMed Central

21 May 2018

http://europepmc.org/abstract/MED/15996703

339

1 reference

Europe PubMed Central

21 May 2018

http://europepmc.org/abstract/MED/15996703

2

1 reference

Europe PubMed Central

21 May 2018

http://europepmc.org/abstract/MED/15996703

213-225

1 reference

Europe PubMed Central

21 May 2018

http://europepmc.org/abstract/MED/15996703

Virus attachment and entry offer numerous targets for antiviral therapy

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.06.008

7 January 2021

HIV-1 integrase: a target for new AIDS chemotherapeutics

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.06.008

7 January 2021

Inhibition of HIV-1 envelope-mediated fusion by synthetic batzelladine analogues.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.06.008

7 January 2021

Mode of action for linear peptide inhibitors of HIV-1 gp120 interactions

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.06.008

7 January 2021

Core structure of gp41 from the HIV envelope glycoprotein

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.06.008

7 January 2021

Determining the structure of an unliganded and fully glycosylated SIV gp120 envelope glycoprotein.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.06.008

7 January 2021

Structure of an unliganded simian immunodeficiency virus gp120 core

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.06.008

7 January 2021

HIV-1 cell entry and advances in viral entry inhibitor therapy

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.06.008

7 January 2021

Novel compounds in preclinical/early clinical development for the treatment of HIV infections

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.06.008

7 January 2021

Three-dimensional structure-activity analysis of a series of porphyrin derivatives with anti-HIV-1 activity targeted to the V3 loop of the gp120 envelope glycoprotein of the human immunodeficiency virus type 1.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.06.008

7 January 2021

Structure-based identification of small molecule antiviral compounds targeted to the gp41 core structure of the human immunodeficiency virus type 1

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.06.008

7 January 2021

Multiple antiviral activities of cyanovirin-N: blocking of human immunodeficiency virus type 1 gp120 interaction with CD4 and coreceptor and inhibition of diverse enveloped viruses

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.06.008

7 January 2021

Beta-turn Phe in HIV-1 Env binding site of CD4 and CD4 mimetic miniprotein enhances Env binding affinity but is not required for activation of co-receptor/17b site

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.06.008

7 January 2021

Analysis of the immunogenic properties of a single-chain polypeptide analogue of the HIV-1 gp120?CD4 complex in transgenic mice that produce human immunoglobulins

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.06.008

7 January 2021

Increased mucosal transmission but not enhanced pathogenicity of the CCR5-tropic, simian AIDS-inducing simian/human immunodeficiency virus SHIV(SF162P3) maps to envelope gp120.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.06.008

7 January 2021

Development of HIV entry inhibitors targeted to the coiled-coil regions of gp41.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.06.008

7 January 2021

Enhancement of human immunodeficiency virus type 1 infection by antisera to peptides from the envelope glycoproteins gp120/gp41

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.06.008

7 January 2021

A screening assay for antiviral compounds targeted to the HIV-1 gp41 core structure using a conformation-specific monoclonal antibody

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.06.008

7 January 2021

Peptide and non-peptide HIV fusion inhibitors

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.06.008

7 January 2021

N-substituted pyrrole derivatives as novel human immunodeficiency virus type 1 entry inhibitors that interfere with the gp41 six-helix bundle formation and block virus fusion

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.06.008

7 January 2021

Structure of an HIV gp120 envelope glycoprotein in complex with the CD4 receptor and a neutralizing human antibody

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.06.008

7 January 2021

Structures of HIV-1 gp120 envelope glycoproteins from laboratory-adapted and primary isolates

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.06.008

7 January 2021

Phage randomization in a charybdotoxin scaffold leads to CD4-mimetic recognition motifs that bind HIV-1 envelope through non-aromatic sequences

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.06.008

7 January 2021

Synthetic bivalent CD4-mimetic miniproteins show enhanced anti-HIV activity over the monovalent miniprotein

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.06.008

7 January 2021

A small molecule HIV-1 inhibitor that targets the HIV-1 envelope and inhibits CD4 receptor binding

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.06.008

7 January 2021

Drug-like properties and the causes of poor solubility and poor permeability

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.06.008

7 January 2021

Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.06.008

7 January 2021

Optimizing the hit-to-lead process using SPR analysis

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.06.008

7 January 2021

New brominated and halogen-less derivatives and structure-activity relationship of azaphilones inhibiting gp120-CD4 binding.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.06.008

7 January 2021

Evidence that the transition of HIV-1 gp41 into a six-helix bundle, not the bundle configuration, induces membrane fusion

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.06.008

7 January 2021

Coreceptors--Implications for HIV Pathogenesis and Therapy

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.06.008

7 January 2021

A peptidomimetic HIV-entry inhibitor directed against the CD4 binding site of the viral glycoprotein gp120.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.06.008

7 January 2021

Inhibition of human immunodeficiency virus replication by RD6-Y664, a novel benzylhydroxylamine derivative

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.06.008

7 January 2021

Isochromophilones I and II, novel inhibitors against gp120-CD4 binding from Penicillium sp.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.06.008

7 January 2021

Conformational changes induced in the human immunodeficiency virus envelope glycoprotein by soluble CD4 binding

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.06.008

7 January 2021

HIV co-receptors as targets for antiviral therapy

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.06.008

7 January 2021

Design and synthesis of novel indole beta-diketo acid derivatives as HIV-1 integrase inhibitors

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.06.008

7 January 2021

Small-molecule inhibitors of HIV-1 entry block receptor-induced conformational changes in the viral envelope glycoproteins

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.06.008

7 January 2021

Analysis of the interaction of an anti-HIV peptide, T22 ([Tyr5, 12, Lys7]-polyphemusin II), with gp120 and CD4 by surface plasmon resonance.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.06.008

7 January 2021

Interaction of an anti-HIV peptide, T22, with gp120 and CD4.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.06.008

7 January 2021

CADA, a novel CD4-targeted HIV inhibitor, is synergistic with various anti-HIV drugs in vitro

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.06.008

7 January 2021

Rational engineering of a miniprotein that reproduces the core of the CD4 site interacting with HIV-1 envelope glycoprotein

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.06.008

7 January 2021

Discovery of 4-benzoyl-1-[(4-methoxy-1H- pyrrolo[2,3-b]pyridin-3-yl)oxoacetyl]-2- (R)-methylpiperazine (BMS-378806): a novel HIV-1 attachment inhibitor that interferes with CD4-gp120 interactions

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.06.008

7 January 2021

The antigenic structure of the HIV gp120 envelope glycoprotein

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.06.008

7 January 2021

Development of a cell-based enzyme-linked immunosorbent assay for high-throughput screening of HIV type 1 entry inhibitors targeting the coreceptor CXCR4.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.06.008

7 January 2021

A novel assay to identify entry inhibitors that block binding of HIV-1 gp120 to CCR5.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.06.008

7 January 2021

A conformation-specific monoclonal antibody reacting with fusion-active gp41 from the human immunodeficiency virus type 1 envelope glycoprotein.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.06.008

7 January 2021

based on heuristic

inferred from DOI database lookup

Conformational changes induced in the envelope glycoproteins of the human and simian immunodeficiency viruses by soluble receptor binding

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.06.008

7 January 2021

based on heuristic

inferred from DOI database lookup

CD4-Induced conformational changes in the human immunodeficiency virus type 1 gp120 glycoprotein: consequences for virus entry and neutralization

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.06.008

7 January 2021

based on heuristic

inferred from DOI database lookup

Synthesis and inhibitory activities of isochromophilone analogues against gp120-CD4 binding

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.06.008

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/J.VIROL.2005.06.008

1 reference

Europe PubMed Central

21 May 2018

http://europepmc.org/abstract/MED/15996703

1 reference

Europe PubMed Central

21 May 2018

http://europepmc.org/abstract/MED/15996703

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q53851964&oldid=1772537252"